Search research articles
Contact Us
Filters
Showing results (1-10 of 122) with videos related to
Page
of 13
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
March 11, 2017
A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry
Rachel D Crouch, J Matthew Hutzler, J Scott Daniels
Analytical Biochemistry
|
April 12, 2003
Development of a method for determination of the malondialdehyde-deoxyguanosine adduct in urine using liquid chromatography-tandem mass spectrometry
Michael Otteneder, J Scott Daniels, Markus Voehler, et al.
Journal of the American Chemical Society
|
July 1, 2004
Kinetic and thermodynamic analysis of the hydrolytic ring-opening of the malondialdehyde-deoxyguanosine adduct, 3-(2'-deoxy-beta-D-erythro-pentofuranosyl)- pyrimido[1,2-alpha]purin-10(3H)-one
James N Riggins, J Scott Daniels, Carol A Rouzer, et al.
Chemical Research in Toxicology
|
November 16, 2004
Enzyme-activated, hypoxia-selective DNA damage by 3-amino-2-quinoxalinecarbonitrile 1,4-di-N-oxide
Goutam Chowdhury, Delshanee Kotandeniya, J Scott Daniels, et al.
Journal of the American Chemical Society
|
September 29, 2007
DNA strand damage product analysis provides evidence that the tumor cell-specific cytotoxin tirapazamine produces hydroxyl radical and acts as a surrogate for O(2)
Goutam Chowdhury, Venkatraman Junnotula, J Scott Daniels, et al.
Journal of the American Chemical Society
|
August 26, 2004
Kinetics and mechanism of the general-acid-catalyzed ring-closure of the malondialdehyde-DNA adduct, N2-(3-oxo-1-propenyl)deoxyguanosine (N2OPdG-), to 3-(2'-Deoxy-beta-D-erythro-pentofuranosyl)pyrimido[1,2-alpha]purin- 10(3H)-one (M1dG)
James N Riggins, Derek A Pratt, Markus Voehler, et al.
Pharmacology Research & Perspectives
|
December 16, 2014
Use of a novel rapid and resource-efficient cassette dosing approach to determine the pharmacokinetics and CNS distribution of small molecule 7-transmembrane receptor allosteric modulators in rat
Thomas M Bridges, Ryan D Morrison, Frank W Byers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 9, 2010
In vitro-in vivo correlation and translation to the clinical outcome for CJ-13,610, a novel inhibitor of 5-lipoxygenase
J Matthew Hutzler, Collette D Linder, Roger J Melton, et al.
Chemical Research in Toxicology
|
April 13, 2006
Oxidative deboronation of the peptide boronic acid proteasome inhibitor bortezomib: contributions from reactive oxygen species in this novel cytochrome P450 reaction
Jason Labutti, Ian Parsons, Ron Huang, et al.
ACS Chemical Neuroscience
|
June 23, 2017
Managing Psychotropic Medications in Complex, Real-World Patients Using Comprehensive Therapeutic Drug Monitoring
Jeffrey J Sutherland, Ryan D Morrison, J Scott Daniels, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 122) with videos related to
Sort By:
Page
of 13
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
March 11, 2017
A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry
Rachel D Crouch, J Matthew Hutzler, J Scott Daniels
Analytical Biochemistry
|
April 12, 2003
Development of a method for determination of the malondialdehyde-deoxyguanosine adduct in urine using liquid chromatography-tandem mass spectrometry
Michael Otteneder, J Scott Daniels, Markus Voehler, et al.
Journal of the American Chemical Society
|
July 1, 2004
Kinetic and thermodynamic analysis of the hydrolytic ring-opening of the malondialdehyde-deoxyguanosine adduct, 3-(2'-deoxy-beta-D-erythro-pentofuranosyl)- pyrimido[1,2-alpha]purin-10(3H)-one
James N Riggins, J Scott Daniels, Carol A Rouzer, et al.
Chemical Research in Toxicology
|
November 16, 2004
Enzyme-activated, hypoxia-selective DNA damage by 3-amino-2-quinoxalinecarbonitrile 1,4-di-N-oxide
Goutam Chowdhury, Delshanee Kotandeniya, J Scott Daniels, et al.
Journal of the American Chemical Society
|
September 29, 2007
DNA strand damage product analysis provides evidence that the tumor cell-specific cytotoxin tirapazamine produces hydroxyl radical and acts as a surrogate for O(2)
Goutam Chowdhury, Venkatraman Junnotula, J Scott Daniels, et al.
Journal of the American Chemical Society
|
August 26, 2004
Kinetics and mechanism of the general-acid-catalyzed ring-closure of the malondialdehyde-DNA adduct, N2-(3-oxo-1-propenyl)deoxyguanosine (N2OPdG-), to 3-(2'-Deoxy-beta-D-erythro-pentofuranosyl)pyrimido[1,2-alpha]purin- 10(3H)-one (M1dG)
James N Riggins, Derek A Pratt, Markus Voehler, et al.
Pharmacology Research & Perspectives
|
December 16, 2014
Use of a novel rapid and resource-efficient cassette dosing approach to determine the pharmacokinetics and CNS distribution of small molecule 7-transmembrane receptor allosteric modulators in rat
Thomas M Bridges, Ryan D Morrison, Frank W Byers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 9, 2010
In vitro-in vivo correlation and translation to the clinical outcome for CJ-13,610, a novel inhibitor of 5-lipoxygenase
J Matthew Hutzler, Collette D Linder, Roger J Melton, et al.
Chemical Research in Toxicology
|
April 13, 2006
Oxidative deboronation of the peptide boronic acid proteasome inhibitor bortezomib: contributions from reactive oxygen species in this novel cytochrome P450 reaction
Jason Labutti, Ian Parsons, Ron Huang, et al.
ACS Chemical Neuroscience
|
June 23, 2017
Managing Psychotropic Medications in Complex, Real-World Patients Using Comprehensive Therapeutic Drug Monitoring
Jeffrey J Sutherland, Ryan D Morrison, J Scott Daniels, et al.
Page
of 13